Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Jonathan Rothschild who wrote (1366)	1/31/1998 12:09:00 AM
From: jackie	Respond to of 2205

Jonathan, No wound healing product sells more because they don't work. Regards, Jack Simmons

To: Jonathan Rothschild who wrote (1366)	1/31/1998 12:46:00 AM
From: Marshall Teitelbaum	Respond to of 2205

Jonathan, Think you're missing the whole point here. Wound care products hav been primitive compared to what's coming out. Hard for one particular product to sell when it rarely stands out above much else, let along if nothing really works well. One, two , or three products come out with specific indications for major problem areas which people have been trying for years to come up with better treatments for, such as diabetic foot ulcers, and you truly believe there will be no difference in the potential market? I'm not trying to be condescending in any way..simply don't agree, but I'd be interested in hearing all opinions here.